CD274 and cancer: Enrichment analysis revealed that these dysregulated OSGs were significantly enriched in pathways related to melanoma, cancer, HIF-1 signaling, FoxO signaling, PI3K-Akt signaling, T-cell receptor signaling, PD-L1 expression and the PD-1 checkpoint pathway, and apoptosis (Figure 2E).